|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| C12N 5/071 | |||
| G01N 33/53 | |||
| G01N 33/68 |
| (11) | Number of the document | 1141028 |
| (13) | Kind of document | T |
| (96) | European patent application number | 99966644.9 |
| Date of filing the European patent application | 1999-12-23 | |
| (97) | Date of publication of the European application | 2001-10-10 |
| (45) | Date of publication and mention of the grant of the patent | 2010-02-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US1999/030895 |
| Date | 1999-12-23 |
| (87) | Number | WO 2000/037504 |
| Date | 2000-06-29 |
| (30) | Number | Date | Country code |
| 113647 P | 1998-12-23 | US |
| (72) |
HANSON, Douglas, Charles, US
NEVEU, Mark, Joseph, US
MUELLER, Eileen, Elliot, US
HANKE, Jeffrey, Herbert, US
GILMAN, Steven, Christopher, US
DAVIS, C., Geoffrey, US
CORVALAN, Jose, Ramon, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
Amgen Fremont Inc., 6701 Kaiser Drive, Fremont, CA 94555, US |
| (54) | HUMAN MONOCLONAL ANTIBODIES TO CTLA-4 |
| HUMAN MONOCLONAL ANTIBODIES TO CTLA-4 |